Magnesiumsulfaat Teva (Magnesium Sulfate)

Magnesium sulfate releases magnesium ions that act as calcium antagonists, stabilising cell membranes, reducing neuronal excitability, and causing vasodilation. These actions help control cardiac rhythm, relax smooth muscle in the airways, and support normal neuromuscular function, which underlies its therapeutic effects.

The specific dose and infusion rate of Magnesiumsulfaat Teva are determined by the prescribing clinician based on the patient’s condition, weight, renal function and therapeutic goal. Healthcare professionals should follow local guidelines and monitor serum magnesium levels during treatment.

Magnesium sulfate is commonly used in obstetric care to prevent eclamptic seizures, and its safety profile in pregnancy is well established when administered under medical supervision. Limited data exist for breastfeeding, but small amounts are excreted in milk; clinicians should weigh benefits against potential risks.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with other electrolyte replacements such as calcium gluconate or potassium chloride, magnesium sulfate uniquely provides calcium‑antagonist effects, vasodilation and anti‑arrhythmic properties. It is the preferred agent for conditions like eclampsia and torsades de pointes, whereas other electrolytes address different deficiencies.

Magnesiumsulfaat Teva should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture and light. Ensure the container is tightly sealed and keep it out of reach of children.

The product is supplied as an injectable solution and can be given intravenously, intra‑articularly or peri‑articularly depending on the clinical indication. Administration should be performed by qualified healthcare personnel using aseptic technique and appropriate infusion devices.

Serious risks include hypermagnesemia leading to respiratory depression, severe hypotension, cardiac arrest, and rare anaphylactic reactions. Continuous monitoring of vital signs and serum magnesium levels is essential, especially in patients with renal impairment or when high doses are used.

Patients with known hypersensitivity to magnesium sulfate, severe renal failure, existing high serum magnesium levels, or those receiving concurrent high doses of calcium channel blockers or neuromuscular blockers should avoid this medication unless closely monitored by a physician.